期刊文献+

经颈静脉肝内门体分流术治疗肝硬化食管胃底静脉曲张破裂出血疗效观察 被引量:2

Transjugular intrahepatic portosystemic stent-shunt in treatment of esophagogastric varices bleeding due to cirrhosis
下载PDF
导出
摘要 目的探讨经颈静脉肝内门体分流术(TIPS)治疗肝硬化食管胃底静脉曲张破裂出血(EGVB)的临床效果。方法收集35例因肝硬化失代偿期合并EGVB行TIPS术的患者的资料,观察近期疗效,包括术后24h止血率、平均门静脉压力、术后肝功能指标(胆碱脂酶、总胆红素、白蛋白)及凝血酶原时间,并与术前比较,并观察肝性脑病及支架阻塞发生情况。结果 35例患者中34例成功实施TIPS,其中1例因血管变异无法经常规路径进入门静脉。术后24h止血率为100%。34例成功实施TIPS的患者,平均门静脉压力从(38.01±4.75)cmH_2O降低至(25 04±3.14)cmH_2O,手术前、后比较,差异有统计学意义(P<0.01)。胆碱脂酶活性、总胆红素、白蛋白、凝血酶原时间术后3d与术前比较,差异均无统计学意义(均P>0.05)。患者术后随访1~12个月,肝性脑病发生率为14.71%(5/34),其中1例严重肝性脑病患者予以再次行TIPS术置入限流支架,病情好转。早期再出血率(72h^6周)为0%(0/34),迟发性再出血率(6周~12个月)为5.88%(2/34),肝功能衰竭发生率为2.94%(1/34),术后支架阻塞率为5.88%(2/34),病死率为0%(0/34)。结论 TIPS治疗肝硬化食管胃底EGVB效果确切,安全可靠。 Objective To evaluate the application of transjugular intrahepatic portosystemic stent- shunt(TIPS) in treatment of esophagogastric varices bleeding (EGVB) in cirrhosis patients. Methods Thirty five patients with EGVB due to liver cirrhosis received TIPS and were fol owed up for 12 months at the First Affiliated Hospital of Wenzhou Medical University and Wenzhou Central Hospital. The short- term effects, including 24h hemostasis rates after TIPS and average portal pressure were observed. The levels of cholinesterase,total bilirubin,albumin,and prothrombin time were also evaluated after TIPS. The occurrence of hep-atic encephalopathy and obstruction of stents after TIPs were also observed. Results The TIPS was successful y performed in 34 out of 35 patients with a total effective rate of 97.14%and the rate of 24h hemostatsis was 100.0%.Average portal pressure dropped from (38.01±4.75)cmH2O to (25.04±3.14) cmH2O after treatment (P〈0.01). There were no significant differences in cholinesterase, total bilirubin,albumin, and prothrombin time before and three days after operation(P〉0.05). The incidence rate of hepatic encephalopathy was 14.71%(5/34).The relapse rate of early rehemorrhagia (72h to 6 weeks) was 0%(0/34) and that of tardive rehaemorrhagia(6 to 12 months) was 5.88%(2/34).The incidence rate of hepatic failure was 2.94%(1/34). The rate of stent obstruction was 5.88%(2/34). No death occurred in the patients. Conclusion TIPS is effective and safe in treatment of esopha-gogastric varices bleeding caused by liver cirrhosis.
出处 《浙江医学》 CAS 2013年第16期1508-1509,1512,共3页 Zhejiang Medical Journal
关键词 经颈静脉肝内门体分流术 食管和胃静脉曲张 肝硬化 Transjugular intrahepatic portasystemic shunt Esophageal and gastric varices Liver cirrhosis
  • 相关文献

参考文献6

  • 1Rossle M,Grandt D. Early Trans jugular intrahepatic portosystemic shunt in patients with cirrhosis and variceal bleeding[J].Hepatolo- gy ,2010,52:1847-1849.
  • 2韩国宏,祁兴顺,樊代明.TIPS治疗肝硬化门脉高压急性静脉曲张出血:救命治疗还是一线治疗?[J].临床肝胆病杂志,2011,27(3):239-240. 被引量:20
  • 3Afdhal N H, Curry M P. Early TIPS to improve survival in acute variceal Bleeding[J].N Engl J meal,2010,362:2421-2422.
  • 4Masson S,Mardini H A,Rose J D,et aI.Hepatic encephalopathy af- ter transjugular intrahepatic portosystemic shunt insertion:a decade ofexperience[J].QJM,2008,101:493-501.
  • 5Haska Z J, Radhakrishnanj. Transjugular intrahepatic portosys- temic shunts in hemodiatysis-dependent patients with advanced renal insufficiency:safety, caution, and encephalopathy[J]. J Vasc I nterv Radiol,2008,19:516-520.
  • 6Stravitz R T, Kramel A H, Davern T, et al. Intensive care of patients with acute liver failure:Recommendations of the U.S. acute liver failure study group[J].Crit Care Med,2007,35: 2498-2508.

二级参考文献19

  • 1Rossle M, Richter GM, Noldge. G, et al. Performance of an intrahepatic portocaval shunt (PCS) using a catheter technique- a case report[J]. Hepatology, 1988, 8:1348A.
  • 2Papatheodoridis GV, Goulis J, Leandro G, et al. Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: a meta-analysis[J]. Hepatology, 1999, 30(3):612-622.
  • 3Luca A, D'Amico G, La Galla R, et al. TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials[J]. Radiology, 1999, 212(2):411-421.
  • 4Burroughs AK, Vangeli M. Transjugular intrahepatic portosystemic shunt versus endoscopic therapy: randomized trials for secondary prophylaxis of variceal bleeding: an updated meta-analysis[J]. Scand J Gastroenterol, 2002, 37(3):249-252.
  • 5Zheng M, Chen Y, Bai J, et al. Transjugular intrahepatic portosystemic shunt versus endscopic therapy in the secondary prophylaxis of variceal rebleeding in cirrhotic patients meta-analysis update[J]. J Clin Gastroenterol, 2008, 42(5):507-516.
  • 6Boyer TD, Haskal ZJ. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension: update 2009[J]. Hepatology, 2010, 51 (1): 306.
  • 7Garcia-Tsao G, Sanyal A J, Grace NG, et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis[J]. Hepatology, 2007, 46(3): 922-938.
  • 8Rossle M. TIPS: an update[J]. Best Prac Res Clin Gastroenterol, 2004, 18(1): 99-123.
  • 9Riggio O, Ridola L, Lucidi S, et al. Emerging issue in the use of transjugular intrahepatic portosystemic shunt (TIPS) for the management of portal hypertension: time to update the guidelines?[J]. Dig Liv Dis, 2010, 42(7):462-467.
  • 10Afdhal NH, Curry MP. Early TIPS to improve survival in acute variceal bleeding[J]. N Engl J Med, 2010, 362(25): 2421-2422.

共引文献19

同被引文献16

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部